期刊文献+

缬沙坦对慢性病毒性心肌炎小鼠Th17/Treg免疫平衡的影响 被引量:1

Valsartan alters the balance of Th17 cells to regulatory T cells in chronic viral myocarditis
原文传递
导出
摘要 目的观察血管紧张素Ⅱ受体拮抗剂(ARB)缬沙坦对慢性病毒性心肌炎(VMC)小鼠Th17与CD4+CD25+Treg细胞的平衡状态及心肌病变的影响,探讨ARB对慢性VMC的作用及其机制。方法以柯萨奇病毒(CVB3)重复增量感染(第1、14、28天剂量分别为0.20、0.25、0.30 mL)BABL/c组小鼠建立慢性VMC模型(n=36),对照组(n=6)同期腹腔注射等体积生理盐水。42 d将慢性VMC模型组存活小鼠随机分为慢性VMC组和缬沙坦组,干预28 d后,处死各组小鼠。处死前测量各组小鼠血压、心脏质量和体质量;脾脏中提取淋巴细胞,采用流式细胞术检测Th17和CD4+CD25+Treg细胞比例;采用Real Time-PCR法检测Foxp3和IL-17的mRNA在心肌中的表达;心肌行HE和Masson染色;心脏超声检查小鼠心脏功能。结果各组小鼠血压水平无显著性差异(P>0.05)。慢性VMC组小鼠心脏质量/体质量比(HW/BW)大于缬沙坦干预组和对照组(P<0.01),慢性VMC组小鼠脾脏中Th17细胞的比例、IL-17、病理积分明显高于缬沙坦组和对照组(P<0.01),而CD4+CD25+Treg细胞的比例、Foxp3低于缬沙坦组和对照组(P<0.05)。缬沙坦组小鼠心功能较慢性VMC组明显改善。结论病毒性心肌炎小鼠外周血中存在Th17/Treg失衡,且与心肌病变有相关性,缬沙坦可通过调节Th17/Treg平衡,减轻慢性VMC自身免疫损伤,避免向扩张型心肌病进展。 Objective To observe the effects of angiotensin receptor U blockers ( ARB ) Valsartan on the balance between Thl7 and Treg cells in chronic viral myocarditis (VMC) and explore the effects of ARB on chronic VMC and its mechanisms. Methods BALB/c mice(n = 36) were infected with CVB3 at day 1,14 and 28 to establish the chronic VMC models. The volumes of CVB3 were 0.20,0.25 and 0.30 mL. The mice in the normal control group ( n = 6) were intraperitoneally injected with equal volumes of normal saline without CVB3 at the same time. The survival mice infecteded with CVB3 were randomly divided into the chronic VMC control group and the Valsartan therapy group at day 42. The mice of the Valsartan therapy group were administered with Valsartan 10 mg/(kg . d) for 28 days. Blood pres- sure, heart weight and body weight of all the mice were measured before execution. Lymphatic cells were extractedfrom the spleen and the ratio of Thl7 and Treg cells was evaluated by flow cytometry, mRNA of IL-17A and foxp3 were tested by Real-time PCR. The severity of myocarditis was assessed by haematoxylin-eosin (HE) and Masson' s trichrome. Echocardiography was performed to evaluate cardiac functions of the mice. Results There was no signifi- cant difference in blood pressure level among the three groups ( P 〉 0. 05 ). Compared with Valsartan group and normal control group, the ratio of heart weight in chronic VMC group was higher,and the percentage of CD4 Thl7 cell and the level of IL-17 in chronic VMC group were significantly up-regulated(P 〈0.01 ), while the pencentage of CD4 + CD25 Treg cell and cytokine of foxp3 was down-regulated (P 〈0.01, P 〈0.05 respectivcly). Cardiac functions of the mice in Valsartan therapy group increased significantly. Conclusion Thl7/Treg imbalance exists in mice with chronic VMC. Valsartan can regulate Thl7/Treg imbalance to ameliorate viral myocarditis and the progression of dilated cardiomyopathy.
出处 《山东大学学报(医学版)》 CAS 北大核心 2013年第2期1-6,11,共7页 Journal of Shandong University:Health Sciences
基金 山东省优秀中青年科学家科研奖励基金(BS2009YY027) 国家自然科学基金(81070188)
关键词 病毒性心肌炎 TH17 TREG 血管紧张素Ⅱ受体拮抗剂 缬沙坦 小鼠 Chronic viral myocarditis Thl7/Treg Angiotensin receptor II blockers Valsartan Mice
  • 相关文献

参考文献19

  • 1Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis[J]. Jam Coll Cardiol, 2012, 59 (9) : 779- 792.
  • 2Taneja V, David C S. Spontaneous autoimmune myocar- ditis and cardiomyopathy In HLA-DQS. NODAbo trans- genicmice[J]. Autoimmun, 2009, 33 (3-4) :260-269.
  • 3Kim Y H, Choi B K, Shin S M, et al. 4-1BB triggering ameliorates experimental autoimmune encephalomyelitisby modulating the balance between Thl7 and regulatory T cells[J]. Immunol, 2011, 187(3) :1120-1128.
  • 4Khoury S J. Thl7 and Treg balance in systemic sclerosis [J]. Clin Immunol, 2011, 139(3) :231-232.
  • 5Xu J, Yang Y, Qiu G. Stat4 is critical for the balance be- tween Thl7 cells and regulatory T cells in colitis[ J]. Im- munol, 2011, 186(11 ) :6597-6060.
  • 6Liu X, Zhu X, Wang A, et al. Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis [J]. Cardiol, 2009, 137(3) :282-288.
  • 7Fairweather D, Rose N R. Coxsackievirus-induced myo- carditis in mice: A model of autoimmune disease for stud- ying immunotoxicity[ J]. Methods, 2007, 41( 1 ) :118-122.
  • 8Caforio A L, Tona F, Bottaro S, et al. Clinical implica- tions of anti-heart autoantibodies in myocarditis and dilat- ed cardiomyopathy [ J]. Autoimmunity, 2008, 41 ( 1 ) : 3545.
  • 9心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:570
  • 10Li T, Fan G X, Wang W, et al. Resveratrol induces ap- optosis, influences IL- 6 and exerts immunomodulatory effect on mouse lymphocytic leukemia both in vitro and in vivo [J]. Int Immunopharmacol, 2007, 7 ( 9 ) : 1221-1231.

二级参考文献68

  • 1王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:63
  • 2张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 3廖玉华,袁璟.扩张型心肌病分子免疫治疗靶点的研究进展[J].中华医学杂志,2006,86(17):1158-1160. 被引量:8
  • 4Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93(5):841-842.
  • 5Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation,2006,113(14):1807-1816.
  • 6Elliott PM,Mckenna WJ.Natural history of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/11502&type=A&selectedTitle=4~58.
  • 7Cooper LT.Definition and classification of the cardiomyopathies.[EB/OL][2006-8-2].http://www.utdol.com.beckerproxy.wustl.edu/applica.../6085&type=A&selectedTitle=2~5.
  • 8McKenna WJ.Genetics of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/9673&type=A&selectedTitle=3~58.
  • 9Poliac LC,Barron ME,Maron BJ.Hypertrophic cardiomyopathy.Anesthesiology,2006,104(1):183-192.
  • 10Maron BJ,Seidman JG,Seidman CE.Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy.J Am Coll Cardiol,2004,44(11):2125-2132.

共引文献569

同被引文献15

  • 1Jeserich M, Brunner E, Kandolf R, et al. Diagnosis of viral myo carditis by cardiac magnetic resonance and viral gcnome detec tion in peripheral blood[J]. International journal of cardiovascu- lar imaging,2013,29(1) : 121-129.
  • 2Corsten MF, Papageorgiou A, Verhesen W, et al. MicroRNA Profiling Identifies MieroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction during Acute Viral MyoCarditis [J]. Circulation research, 2012,111 (4) : 415-425.
  • 3Li YE, Ge LS, Guan XQ, et al. The mechanism of carvedilol in experimental viral myocarditis[J]. Current pharmaceutical de- sign,2012,18(12) : 1620-1624.
  • 4AI-Biltagi M,Issa M,Hagar HA,et al. Circulating cardiac tro- ponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis[J].Acta paediatrica,2010, 99(10); 1510 1516.
  • 5Yuan J, Yu M, Lin QW, et al. Neutralization of IL-17 inhibits the production of anti-ANT autoantibodies in CVB3-induced a cute viral myocarditis[J]. International immunopharmacology, 2010, 10(3) :272-276.
  • 6Abston ED, Coronado MJ, Bucek A, et al. TLR3 deficiency in- duces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4[J]. Ameri- can Journal of Physiology, 2013,304(2) : 267-277.
  • 7章惠刚,付美丽,赵沛光,李建祖.病毒性心肌炎患者外周血红细胞免疫功能的变化和血清cTnI水平的相关性分析[J].放射免疫学杂志,2010,23(2):203-205. 被引量:9
  • 8杨克平,张云峰,李欣.扩张型心肌病患者Th17/Treg的变化及意义[J].微循环学杂志,2011,21(1):32-34. 被引量:9
  • 9裴丽,张军平.病毒性心肌炎诊断的研究进展[J].实用儿科临床杂志,2011,26(10):795-797. 被引量:29
  • 10赵燕,刘爱玲,许耀,于春英,孙允龙,樊龙昌.重症病毒性心肌炎的临床分析(附12例报告)[J].临床心血管病杂志,2011,27(9):695-696. 被引量:6

引证文献1

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部